Literature DB >> 303417

Studies on production of biologically active substance which inhibits the intracellular multiplication of Toxoplasma within mouse macrophages.

T Shirahata, K Shimizu, S Noda, N Suzuki.   

Abstract

In vitro assessments were carried out to study some biological aspects of immune lymphocytes producing a new lymphokine, called by the authors Toxoplasma growth inhibitory factor (Toxo-GIF), which inhibits the intracellular multiplication of Toxoplasma gondii within nonimmune mouse macrophages. Concanavalin A and phytohemagglutinin-P were found to induce vigorous production of Toxo-GIF, whereas bacterial lipopolysaccharide did not. In vitro treatment of splenic lymphocytes with rabbit anti-mouse thymocyte serum plus complement abolished almost completely their ability to produce Toxo-GIF. Treatment of splenic lymphocytes with inhibitors of protein synthesis, cycloheximide or puromycin resulted in a remarkable reduction of the ability of sensitized lymphocytes to produce this lymphokine. Thus the production of Toxo-GIF seems to be dependent on the cellular metabolic events of sensitized T-lymphocytes. The significant activity of Toxo-GIF was demonstrable even in the supernate of lymphocyte cultures incubated in serum-free medium and was also evident after immune lymphocytes and homologous antigen were incubated for the relatively short period of 10 h.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303417     DOI: 10.1007/bf00383112

Source DB:  PubMed          Journal:  Z Parasitenkd        ISSN: 0044-3255


  16 in total

1.  An in vitro study on lymphocyte-mediated immunity in mice experimentally infected with Toxoplasma gondii.

Authors:  T Shirahata; K Shimizu; N Suzuki
Journal:  Nihon Juigaku Zasshi       Date:  1975-06

2.  Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis.

Authors:  D L Cahall; G P Youmans
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

3.  Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter.

Authors:  B M Greene; D G Colley
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

4.  Feline viruses. V. Serum-neutralization test for feline panleukopenia.

Authors:  F W Scott; C K Csiza; J H Gillespie
Journal:  Cornell Vet       Date:  1970-04

5.  Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.

Authors:  W P Kolb; G A Granger
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

6.  Partial characterization of murine migration inhibitory factor (MIF).

Authors:  A L Kühner; J R David
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

7.  In vitro studies on the mechanism of acquired resistance to tuberculous infection. I. The relationship between lymphocytes and macrophages in cellular immunity to tuberculous infection.

Authors:  S Muraoka; K Takeya; K Nomoto
Journal:  Jpn J Microbiol       Date:  1976-04

8.  Eosinophils and immune mechanisms. III. Production of the lymphokine eosinophil stimulation promoter by mouse T lymphocytes.

Authors:  B M Greene; D G Colley
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

9.  Activation of mouse peritoneal cells to kill Listeria monocytogenes by T-lymphocyte products.

Authors:  P Cole
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

10.  Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.

Authors:  J S Borges; W D Johnson
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  6 in total

1.  Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells.

Authors:  M Chinchilla; J K Frenkel
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

3.  Toxoplasmosis in immunoglobulin M-suppressed mice.

Authors:  J K Frenkel; D W Taylor
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

Review 5.  Role of gamma interferon in Toxoplasma gondii infection.

Authors:  C S Subauste; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

6.  Cellular immunity of mice to Leishmania donovani in vitro: lymphokine-mediated killing of intracellular parasites in macrophages.

Authors:  K P Chang; J W Chiao
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.